Skip to main content

Advertisement

Table 1 Demographics and clinical characteristics of Patients with NAFLD and Controlsa

From: Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study

Characteristics NAFLD patients (n = 182) Controls (n = 195) p Value
Age, y 46.09 ± 11.59 40.64 ± 11.53 0.000
Gender, Female/Male 97/85 107/88 0.759
Height, cm 167.17 ± 10.55 166.09 ± 6.46 0.237
Weight, kg 74.28 ± 11.44 63.38 ± 11.10 0.000
Waist circumference, cm 92.29 ± 9.29 82.46 ± 8.85 0.000
Hip circumference, cm 103.11 ± 8.21 96.87 ± 8.80 0.000
ALT, U/L 25.63 ± 14.41 19.71 ± 10.49 0.000
AST, U/L 21.90 ± 11.23 19.64 ± 6.46 0.018
GGT, U/L 22.19 ± 9.62 14.88 ± 5.69 0.000
TBIL, umol/L 13.95 ± 6.40 13.36 ± 5.30 0.329
AKP, U/L 68.18 ± 18.35 59.79 ± 13.81 0.000
GLU, mmol/L 5.57 ± 1.79 4.96 ± 1.20 0.000
UA, umol/L 364.42 ± 187.65 301.10 ± 76.82 0.000
TG, mmol/L 1.98 ± 1.78 1.27 ± 1.58 0.000
TC, mmol/L 4.92 ± 0.95 4.64 ± 0.93 0.004
HDL, mmol/L 1.29 ± 0.46 1.48 ± 0.33 0.000
LDL, mmol/L 3.30 ± 0.93 2.94 ± 0.80 0.000
  1. Abbreviation: ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT gamma-glutamyltranspeptidase, TBIL Total bilirubin, AKP alkaline phosphatase, GLU glucose, UA Uric acid, TG Triglyceride, TC Total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. aData are presented as Mean ± SD